We read with interest the article by Johnson and colleagues [1] reporting a huge increase in the odds of artificial reproductive technique (ART) pregnancies among fetuses with BeckwithWiedemann spectrum (BWSp) presenting with omphalocele. Their valuable report further strengthens the association between ART and imprinting disorders. However, several points deserve to be commented on.
questionnaire surveys providing indirect estimates by relating the ART rate observed in BWSp cohorts to that observed in the general population at the time of the investigation. Johnson and colleagues' estimate, however, is almost twofold the highest and most recent data reported (RR 10.7) [2] , which is also the first direct estimate based on the comparison of BWSp incidence in ART and non-ART cohorts in a defined time window. We think that the odds the authors provided are barely comparable with data previously reported in literature. The 20-fold estimate refers to the risk of ART in fetuses with BWSp + omphalocele in a prenatal setting, not to the odds of ART in BWSp, and, moreover, is likely to be largely overestimated due to several factors.
First, the authors assumed a BWSp + omphalocele prevalence of 1/17,000, using a BWSp prevalence of 1/13,700 [3] and considering omphalocele present in 80% of BWSp patients. Actually, more recent BWSp prevalence estimates in the general population is higher (nearly 1/10,500) [4] , while recent genotype-phenotype studies indicate that only 32% of BWS patients have omphalocele [5] [6] [7] [8] , thus resulting in an estimate prevalence of BWS + omphalocele of about 1/ 32,800. Therefore, they calculated the overall risk of BWSp + omphalocele following ART of about 1/850 (i.e., 1/17,000 per 20-fold odds); while using more recent data, it would be about 1/1640. However, the latter prevalence is nevertheless overestimated. Indeed, considering that BWSp prevalence in ART population is~1/1100 [2] , the maximum risk of BWSp + omphalocele following ART can be approximated to be 1/ 3400 (i.e., 32% of 1/1100). This is to be considered a maximum estimate as omphalocele was reported to be less common in patients with BWSp conceived through ART than in those naturally conceived (11-35% [5] [9] vs 32%).
Second, the authors' rough estimate should additionally be lowered taking into account that CDKN1C mutation analysis was not performed and that this defect is neither epigenetic nor associated with ART: as pointed out, CDKN1C mutation accounts for < 5% of BWSp molecular anomalies, but CDKN1C-mutated phenotypes have an omphalocele incidence more than twofold that reported in the other molecular defects [6] . Hence, CDKN1C mutation incidence is expected to be higher than 5% in a cohort of BWSp + omphalocele.
Third, there is a selection bias in the study. Omphalocele is notably associated with centromeric molecular defects (imprinting center 2-IC2-hypomethylation and CDKN1C mutation). BWSp cohort pooled data [5] indicate that > 85% of omphalocele occur in patients with IC2 hypomethylation and are consistent with the findings of the authors (36/40). IC2 hypomethylation, however, is also associated with BWSp-ART, representing more than 90% of the molecular anomalies, in contrast to the~50% of non-ART-BWSp [10] . Thus, the authors should expect these two associations to be responsible for an overrepresentation of ART pregnancies in BWSp + omphalocele fetuses.
It is of interest to investigate whether additional BWSp prenatal signs were present and the postnatal phenotype disclosed in the described BWSp cases: this study confirms that a relevant fraction (13-20% [11] ) of fetuses with omphalocele have BWSp. This is relevant as it is debated whether testing or not for BWSp infants presenting with isolated omphalocele (European BWSp Consensus [12] , recommendation 4).
As a final point, the authors described a case of BWSp-ART with chromosome 11 paternal uniparental disomy (UPD), which occurrence in ART pregnancies is almost anecdotal [2] given that most molecular anomalies in ART-BWSp are related to imprinting defects. While most research on ART-related imprinting disorders hypothesized methylation disturbances arising in the oocyte or in the male gamete [10] , UPD likely results from post-fertilization somatic recombination, supporting therefore a pathogenetic role of embryo manipulation. In this respect, further genomic characterization of the region involved in UPD may be crucial in these cases to insight the molecular mechanisms responsible for ARTassociated developmental defects.
